European public procurement and grants data from official registers · Data as of 19 November 2026; updated daily.

Market report

Dermatological drug tenders in Czechia — market report, April 2025

Dermatological drug tenders in Czechia in April 2025: 8,045 tenders published (-9% month on month, +19% year on year), estimated at €6,934,584 in total, and 8,051 contracts awarded (-9% month on month, +19% year on year), worth €5,714,987 (awarded value). Buyers with the most tenders: Fakultní nemocnice Bulovka (2,329), Krajská nemocnice T. Bati, a. s. (1,977) and Krajská zdravotní, a.s. (811); most contracts won: ViaPharma s.r.o. (372), ROCHE s.r.o. (234) and Janssen-Cilag s.r.o. (152). On average 1.1 bids per contract; 90% of contracts had a single bid. Report made on 27 October 2026.

Tenders published
8,045
Contracts awarded
8,051
Contract value awarded
€5,714,987
Bids per contract
1.1
Tenders published per month
05K10KApr 24: 6,740Apr 24: 6,740Apr 24May 24: 6,773May 24: 6,773May 24Jun 24: 6,695Jun 24: 6,695Jun 24Jul 24: 5,647Jul 24: 5,647Jul 24Aug 24: 5,777Aug 24: 5,777Aug 24Sep 24: 5,695Sep 24: 5,695Sep 24Oct 24: 7,005Oct 24: 7,005Oct 24Nov 24: 6,299Nov 24: 6,299Nov 24Dec 24: 6,565Dec 24: 6,565Dec 24Jan 25: 4,714Jan 25: 4,714Jan 25Feb 25: 9,302Feb 25: 9,302Feb 25Mar 25: 8,827Mar 25: 8,827Mar 25Apr 25: 8,045Apr 25: 8,0458,045Apr 25
Contracts awarded per month
05K10KApr 24: 6,746Apr 24: 6,746Apr 24May 24: 6,771May 24: 6,771May 24Jun 24: 6,702Jun 24: 6,702Jun 24Jul 24: 5,647Jul 24: 5,647Jul 24Aug 24: 5,776Aug 24: 5,776Aug 24Sep 24: 5,682Sep 24: 5,682Sep 24Oct 24: 7,008Oct 24: 7,008Oct 24Nov 24: 6,301Nov 24: 6,301Nov 24Dec 24: 6,569Dec 24: 6,569Dec 24Jan 25: 4,725Jan 25: 4,725Jan 25Feb 25: 9,292Feb 25: 9,292Feb 25Mar 25: 8,846Mar 25: 8,846Mar 25Apr 25: 8,051Apr 25: 8,0518,051Apr 25

The highlighted bar is April 2025. Hover a bar for its figure; the table below has every value.

FigureApril 2025March 2025ChangeApril 2024Change
Tenders published8,0458,827-9%6,740+19%
Estimated value€6,934,584€167,261+4,046%€1,849,242+275%
Buyers3134-9%32-3%
Contracts awarded8,0518,846-9%6,746+19%
Contract value (awarded)€5,714,987€26,562,599-78%€51,985+10,894%
Winners264279-5%284-7%
Bids per contract1.11.4—3.7—
Single-bid contracts90%75%—43%—

Buyers with the most tenders

Companies with the most contracts

Where the tenders were

  • Hlavní město Praha 12
  • Olomoucký kraj 5
  • Královéhradecký kraj 2
  • Moravskoslezský kraj 1

Procedures

  • not stated 8,025
  • Open procedure 18
  • Other procedure 2

Download the figures (CSV)

The report's aggregates: the figures, the comparisons and the top lists by name and count.

All reports: Dermatological and musculoskeletal drugs

Questions and answers

How many dermatological drug tenders were published in Czechia in April 2025?
8,045 (by 31 buyers); for comparison, March 2025: 8,827, April 2024: 6,740.
Who won the most dermatological drug tenders in Czechia in April 2025?
By number of contracts: ViaPharma s.r.o. (372), ROCHE s.r.o. (234), Janssen-Cilag s.r.o. (152), Merck Sharp & Dohme s.r.o. (142) and Amgen s.r.o. (119); 264 companies won contracts in all.
Which buyers published the most dermatological drug tenders in April 2025?
Fakultní nemocnice Bulovka (2,329), Krajská nemocnice T. Bati, a. s. (1,977), Krajská zdravotní, a.s. (811), Fakultní nemocnice Brno (375) and Nemocnice České Budějovice, a.s. (297).
How competitive were dermatological drug tenders in Czechia in April 2025?
On average 1.1 bids per contract (20 contracts with a known number of bids); 90% of contracts had a single bid.
What were the contracts worth in April 2025?
€5,714,987 (awarded value, 8,051 contracts); median about €550,000.

How the report is made

Tenders published: the tenders of the sector or topic whose first notice is dated in the month (a tender counts in its sector and in up to three topics). Contracts awarded: the awards dated in the month, whenever their tender was published. Values in EUR, by value kind (never added together); medians are approximate (±3 %). Comparisons: with the reports of the previous month and of the same month a year earlier, each made the same way. The report was made on 27 October 2026 from the data of that day and is not changed afterwards; sources publish late, so later data for the month are not in it.